Overview
Jean-charles Portais practices practicing medicine in Toulouse, France.
Their clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, and Fibrosarcoma.
They are actively involved in clinical research, co-authoring 73 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Jean-charles C. Portais
Is Jean-charles C. Portais a top-rated expert for Acute Myeloid Leukemia (AML)?
MediFind is an objective health platform that identifies experts based on real-world data. Jean-charles C. Portais is classified as an Experienced expert for Acute Myeloid Leukemia (AML), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Jean-charles C. Portais participate in research or clinical trials?
Yes. Jean-charles C. Portais has published 73 articles and abstracts on conditions like Acute Myeloid Leukemia (AML). You can view a list of Jean-charles C. Portais's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acute Myeloid Leukemia (AML)Portais isExperienced. Learn about Acute Myeloid Leukemia (AML).
- FibrosarcomaPortais isExperienced. Learn about Fibrosarcoma.
- LeukemiaPortais isExperienced. Learn about Leukemia.